Trial Profile
Retrospective study to assess the safety and efficacy of Vedolizumab in patients with Inflammatory Bowel Disease in a real-world setting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2017
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Adverse reactions; Therapeutic Use
- 06 Jan 2017 New trial record